Characteristics and Outcomes of U.S. Children and Adolescents with MIS-C by Dr. Adrienne Randolph

Explore a 25-minute podcast featuring Dr. Adrienne Randolph as she delves into the epidemiology, clinical characteristics, and outcomes of pediatric patients with Severe Acute COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C). Gain insights into distinguishing features between these conditions to aid in timely and effective treatment. Learn to contrast key clinical characteristics of MIS-C versus severe acute COVID-19 in children and adolescents, and understand concerns related to pediatric COVID-19 vaccine development and public health measures like school reopening. The podcast references several important studies and articles, providing a comprehensive overview of the topic. Suitable for healthcare providers seeking to enhance their knowledge of pediatric COVID-19 and MIS-C.

• Feldstein LR, Tenforde MW, Friedman KG, et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children MIS-C Compared With Severe Acute COVID-19. JAMA. 2021;32511:1074-1087. doi:10.1001/jama.2021.2091
• Ferdinands JM, Olsho LE, Agan AA, et al. Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. J Infect Dis. 2014;2105:674-683. doi:10.1093/infdis/jiu185
• Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N Engl J Med. 2020;3834:334-346. doi:10.1056/NEJMoa2021680
• Truong DT, Trachtenberg FL, Pearson GD, et al. The NHLBI Study on Long-terM OUtcomes after the Multisystem Inflammatory Syndrome In Children MUSIC: Design and Objectives. Am Heart J. 2022;243:43-53. doi:10.1016/j.ahj.2021.08.003
• LaRovere KL, Riggs BJ, Poussaint TY, et al. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurol. 2021;785:536-547. doi:10.1001/jamaneurol.2021.0504